Literature DB >> 12032683

Gene therapy and the public: a matter of trust.

H Gottweis1.   

Abstract

The relationship between genetic engineering and the public has never been a very harmonious one. Many scientists believe that public concerns about gene therapy are simply based on misunderstandings and lack of scientific information. In this 'deficit theory' of the public, most difficulties in the interaction between science and the public are derived from the assumption that there is a communication gap between scientists and the public. However, public opinion research shows clearly that the various 'publics' have a differentiated, and generally positive perception of medical biotechnology. It is not so much lack of information, as lack of trust which explains the difficult relationship between gene therapy and society. For the future, it will be crucial not only to focus on the idea of 'educating the public', but to find new communicative and institutional formats to generate trust.

Keywords:  Genetics and Reproduction

Mesh:

Year:  2002        PMID: 12032683     DOI: 10.1038/sj.gt.3301752

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

1.  Protection at the cutting edge: the case for central review of human gene transfer research.

Authors:  Jonathan Kimmelman
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  Hype and public trust in science.

Authors:  Zubin Master; David B Resnik
Journal:  Sci Eng Ethics       Date:  2011-11-02       Impact factor: 3.525

Review 3.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Promoting public awareness and engagement in genome sciences.

Authors:  Susanne B Haga; Katie D Rosanbalm; Larry Boles; Genevieve M Tindall; Troy M Livingston; Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2013-02-23       Impact factor: 2.537

5.  The attitude of oncology physicians and nurses to the acceptance of new drugs for gene therapy.

Authors:  Zi-ming Liu; Chang Liu; Jun-ying Li; Chun-hua Yu; Yu Jiang
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

6.  Survey of US public attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; I R Lipkus; R Agans
Journal:  Pharmacogenomics J       Date:  2011-02-15       Impact factor: 3.550

7.  Enhancing geneticists' perspectives of the public through community engagement.

Authors:  Julianne M O'Daniel; Katie D Rosanbalm; Larry Boles; Genevieve M Tindall; Troy M Livingston; Susanne B Haga
Journal:  Genet Med       Date:  2012-01-19       Impact factor: 8.822

8.  Experiences and attitudes of residents regarding a community-based genome cohort study in Japan: a population-based, cross-sectional study.

Authors:  Keiko Miyamoto; Miho Iwakuma; Takeo Nakayama
Journal:  BMC Med Genomics       Date:  2016-03-15       Impact factor: 3.063

9.  Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.

Authors:  Tanya M Bardakjian; Kaylee Faulkner Naczi; Pedro Gonzalez-Alegre
Journal:  J Huntingtons Dis       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.